Constitutive Activation of the Janus Kinase-STAT Pathway in T Lymphoma Overexpressing the Lck Protein Tyrosine Kinase

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5206-5210

  Yu, Chao Lan ^a   Jove, Richard ^b   Burakoff, Steven J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA BINDING PROTEIN; JAK3 PROTEIN, HUMAN; JAK3 PROTEIN, MOUSE; JAK3 PROTEIN, RAT; JANUS KINASE 3; MILK PROTEIN; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; STAT1 PROTEIN, MOUSE; STAT1 PROTEIN, RAT; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE; STAT3 PROTEIN, RAT; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; CELL STRAIN 3T3; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; LEUKEMIA CELL LINE; METABOLISM; MOUSE; RAT; SIGNAL TRANSDUCTION; T CELL LYMPHOMA;

3T3 CELLS; ANIMALS; CELL LINE, TRANSFORMED; DNA; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HUMANS; JANUS KINASE 3; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; MILK PROTEINS; PROTEIN-TYROSINE KINASES; RATS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0031306869     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Marth, J. D., R. Peet, E. G. Krebs, and R. M. Perlmutter. 1985. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell 43:393.
2. Voronova, A. F., and B. M. Sefton. 1986. Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion. Nature 319:682.
3. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585.
4. Ravichandran, K. S., T. L. Collins, and S. J. Burakoff. 1996. CD4 and signal transduction. Curr. Top. Microbiol. Immunol. 205:47.
5. lck in T cell signaling and thymocyte development. Adv. Immunol. 56:151.
6. lck. Proc. Natl. Acad. Sci. USA 88:3977.
7. Wright, D. D., B. M. Sefton, and M. P. Kamps. 1994. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia. Mol. Cell. Biol. 14:2429.
8. Garvin, A. M., S. Pawar, J. D. Marth, and R. M. Perlmutter. 1988. Structure of the murine lck gene and its rearrangement in a murine lymphoma cell line. Mol. Cell. Biol. 8:3058.
9. Hurley, T. R., and B. M. Sefton. 1989. Analysis of the activity and phosphorylation of the Lck protein in lymphoid cells. Oncogene 4:265.
10. lck). Mol. Cell. Biol. 8:540.
11. Marth, J. D., C. Disteche, D. Pravtcheva, F. Ruddle, E. G. Krebs, and R. M. Perlmutter. 1986. Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas. Proc. Natl. Acad. Sci. USA 83:7400.
12. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
13. Ihle, J. N. 1995. Cytokine receptor signalling. Nature 377:591.
14. Taniguchi, T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251.
15. Tum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J. 14:1412.
16. Carlesso, N., D. A. Frank, and J. D. Griffin. 1996. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183:811.
17. Tortolani, P. J., B. K. Lal, A. Riva, J. A. Johnston, Y. Q. Chen, G. H. Reaman. M. Beckwith, D. Longo, J. R. Ortaldo, K. Bhatia, I. McGrath, J. Kehrl, J. Tuscano, D. W. McVicar, and J. J. O'Shea. 1995. Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J. Immunol. 155: 5220.
18. Migone, T. S., J. X. Lin, A. Cereseto, J. C. Mulloy, J. J. O'Shea, G. Franchini, and W. J. Leonard. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79.
19. Weber-Nordt, R. M., C. Egen, J. Wehinger. W. Ludwig, V. Gouilleux-Gruart, R. Mertelsmann, and J. Finke. 1996. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809.
20. Gouilleux-Gruart, V., F. Gouilleux, C. Desaint, J. F. Claisse, J. C. Capiod, J. Delobel, R. Weber-Nordt, I. Dusanter-Fourt, F. Dreyfus, B. Groner, and L. Prin. 1996. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692.
21. Yu, C-L., D. J. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz, and R. Jove. 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81.
22. Campbell, G. S., C-L. Yu, R. Jove, and C. Carter-Su. 1997. Constitutive activation of JAK1 in Src-transformed cells. J. Biol. Chem. 272:2591.
23. Cao, X., A. Tay, G. R. Guy, and Y. H. Tan. 1996. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 16:1595.
24. Danial, N. N., A. Pernis, and P. B. Rothman. 1995. Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875.
25. Zong, C., R. Yan, A. August, J. E. Darnell, Jr., and H. Hanafusa. 1996. Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J. 15:4515.
26. Meydan, N., T. Grunberger, H. Dadi, M. Shahar, E. Arpaia, Z. Lapidot, J. S. Leeder, M. Freedman, A. Cohen, A. Gazit, A. Levitzki, and C. M. Roifman. 1996. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379:645.
27. Sawasdikosol, S., K. S. Ravichandran, K. K. Lee, J. H. Chang, and S. J. Burakoff. 1995. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J. Biol. Chem. 270:2893.
28. Fruman, D. A., S. Y. Pai, S. J. Burakoff, and B. E. Bierer. 1995. Characterization of a mutant calcineurin Aa gene expressed by EL4 lymphoma cells. Mol. Cell. Biol. 15:3857.
29. lck, reveals its oncogenic potential in fibroblasts. Proc. Natl. Acad. Sci. USA 85:4247.
30. Yu, C-L., and S. J. Burakoff. 1997. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation. J. Biol. Chem. 272:14017.
31. Uchiyama, T. 1996. ALL and HTLV-I: in vivo cell growth of ATL cells. J. Clin. Immunol. 16:305.
32. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259.
33. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169.
34. Johnston, J. A., C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan, K. Shibuya, J. R. Ortaldo, S. Gupta, Y. Q. Chen, J. D. Giri, and J. J. O'Shea. 1995. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 92:8705.